Genetic Modulation of GABA Levels in the Anterior Cingulate Cortex by GAD1 and COMT
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
γ-Aminobutyric acid (GABA)-ergic transmission is critical for normal cortical function and is likely abnormal in a variety of neuropsychiatric disorders. We tested the in vivo effects of variations in two genes implicated in GABA function on GABA concentrations in prefrontal cortex of living subjects: glutamic acid decarboxylase 1 (GAD1), which encodes GAD67, and catechol-o-methyltransferase (COMT), which regulates synaptic dopamine in the cortex. We studied six single nucleotide polymorphisms (SNPs) in GAD1 previously associated with risk for schizophrenia or cognitive dysfunction and the val158met polymorphism in COMT in 116 healthy volunteers using proton magnetic resonance spectroscopy. Two of the GAD1 SNPs (rs1978340 (p=0.005) and rs769390 (p=0.004)) showed effects on GABA levels as did COMT val158met (p=0.04). We then tested three SNPs in GAD1 (rs1978340, rs11542313, and rs769390) for interaction with COMT val158met based on previous clinical results. In this model, rs11542313 and COMT val158met showed significant main effects (p=0.001 and 0.003, respectively) and a trend toward a significant interaction (p=0.05). Interestingly, GAD1 risk alleles for schizophrenia were associated with higher GABA/Cre, and Val-Val homozygotes had high GABA/Cre levels when on a GAD1 risk genotype background (N=6). These results support the importance of genetic variation in GAD1 and COMT in regulating prefrontal cortical GABA function. The directionality of the effects, however, is inconsistent with earlier evidence of decreased GABA activity in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Conflict monitoring versus selection-for-action in anterior cingulate cortex
Botvinick, M., Nystrom, L. E., Fissell, K., Carter, C. S., & Cohen, J. D. (1999) · Nature · doi:10.1038/46035 · Cited by 2,044
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · cited 1×
“GABA-ergic function is critical for numerous aspects of cognition (Gao and Goldman-Rakic, 2003a; Goldman-Rakic, 1990; Menzies et al , 2007; Seamans and Yang, 2004) and its alterations have been implicated in a number of neuropsychiatric disorders, including epilepsy (Wong et al , 2003),…”
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864 · cited 1×
“…implications for GABA function and risk for schizophrenia is catechol-o-methyl-transferase ( COMT ), an enzyme that regulates cortical DA levels (Gogos et al , 1998; Karoum et al , 1994) and likely GABA neuronal excitability (Seamans et al , 2001), perhaps particularly during development (Tseng…”
Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., & Diatchenko, L. (2006) · Science · doi:10.1126/science.1131262 · Cited by 848
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846 · cited 2×
“This same methodology has also been shown to be sensitive to the effects of disease and has shown expected reductions of GABA levels in depression (Hasler et al , 2007).”
Self-citationSanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627 · cited 1×
“…2003a; Goldman-Rakic, 1990; Menzies et al , 2007; Seamans and Yang, 2004) and its alterations have been implicated in a number of neuropsychiatric disorders, including epilepsy (Wong et al , 2003), schizophrenia (Lewis and Hashimoto, 2007; Lewis et al , 2005) and depression (Sanacora et al , 1999).”
High-Resolution Mapping of Expression-QTLs Yields Insight into Human Gene Regulation
Veyrieras, J.-B., Kudaravalli, S., Kim, S. Y., Dermitzakis, E. T., Gilad, Y., Stephens, M., & Pritchard, J. K. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000214 · Cited by 536 · cited 1×
“…, 2006) in the case of rs11542313 (a synonymous coding SNP); being part of a regulatory element in the 5 ′ flanking region in the case of rs1978340 (Veyrieras et al , 2008), or in an intron for rs769390; monitoring other rare causative SNPs via linkage disequilibrium; or modification of…”
Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons
Seamans, J. K., Gorelova, N., Durstewitz, D., & Yang, C. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03628.2001 · Cited by 507 · cited 1×
“…( COMT ), an enzyme that regulates cortical DA levels (Gogos et al , 1998; Karoum et al , 1994) and likely GABA neuronal excitability (Seamans et al , 2001), perhaps particularly during development (Tseng et al , 2007), and would thus be expected to modulate GABA function.”
Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490
Cited by
Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
Mei, L., & Nave, K.-A. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.007 · Cited by 592
Rae, C. D. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1199-5 · Cited by 496
Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels
Gao, F., Edden, R. A. E., Li, M., Puts, N. A. J., Wang, G., Liu, C., Zhao, B., Wang, H., Bai, X., Zhao, C., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.012 · Cited by 285
Discovering imaging endophenotypes for major depression
Hasler, G., & Northoff, G. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.23 · Cited by 274
Reduced GABA Concentration in Attention-Deficit/Hyperactivity Disorder
Edden, R. A. E., Crocetti, D., Zhu, H., Gilbert, D. L., & Mostofsky, S. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2280 · Cited by 264
The future of ultra-high field MRI and fMRI for study of the human brain
Duyn, J. H. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.065 · Cited by 261
Rosso, I. M., Weiner, M. R., Crowley, D. J., Silveri, M. M., Rauch, S. L., & Jensen, J. E. (2014) · Depression and Anxiety · doi:10.1002/da.22155 · Cited by 101
“[37–39] These regressions entered group and the aforementioned covariates using amixed-entry procedure with entry and removal probabilities of .”
MethodCiuculete, D. M., Boström, A. E., Voisin, S., Philipps, H., Titova, O. E., Bandstein, M., Nikontovic, L., Williams, M. J., Mwinyi, J., & Schiöth, H. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.275 · Cited by 40
Interactive effects of OXTR and GAD1 on envy-associated behaviors and neural responses
Tanaka, T., Nishimura, F., Kakiuchi, C., Kasai, K., Kimura, M., & Haruno, M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210493 · Cited by 9
Metadata
- Authors
- Marenco, S., Savostyanova, A. A., van der Veen, J. W., Geramita, M., Stern, A., Barnett, A. S., Kolachana, B., Radulescu, E., Zhang, F., Callicott, J. H., Straub, R. E., Shen, J., & Weinberger, D. R.
- Venue
- Neuropsychopharmacology
- Published
- 2010-03-31
- Volume
- 35
- Issue
- 8
- Pages
- 1708-1717
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2019182935
- Cited by
- 73
- References
- 18
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.